Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples
- PMID: 38796134
- DOI: 10.1016/j.jviromet.2024.114956
Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples
Abstract
Wastewater-based epidemiology has proved to be a suitable approach for tracking the spread of epidemic agents including SARS-CoV-2 RNA. Different protocols have been developed for quantitative detection of SARS-CoV-2 RNA from wastewater samples, but little is known on their performance. In this study we compared three protocols based on Reverse Transcription Real Time-PCR (RT-PCR) and one based on Droplet Digital PCR (ddPCR) for SARS-CoV-2 RNA detection from 35 wastewater samples. Overall, SARS-CoV-2 RNA was detected by at least one method in 85.7 % of samples, while 51.4 %, 22.8 % and 8.6 % resulted positive with two, three or all four methods, respectively. Protocols based on commercial RT-PCR assays and on Droplet Digital PCR showed an overall higher sensitivity vs. an in-house assay. The use of more than one system, targeting different genes, could be helpful to increase detection sensitivity.
Keywords: Digital PCR; Droplet digital PCR; Environmental surveillance; Reverse transcription real-time PCR; SARS-CoV-2; Wastewater; Wastewater-based epidemiology.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest G.M.R. reports grants, consulting fees, and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from bioMérieux, MSD, Shionogi, Zambon, Menarini, Angelini; grants from Accelerate, Cepheid, Nordic Pharma, Seegene, Arrow, Symcel, DID, Hain Lifescience, Meridian, Setlance, Qvella, Qlinea, Biomedical Service, Quidel, QuantaMatrix, SD Biosensor; consulting fees from Pfizer and Qiagen; payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Becton Dickinson, Cepheid and Pfizer, outside the submitted work. All other authors declare no competing interests.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous